It is a pharma private limited company based in Kadugodi, Karnataka, India, established in 2021.
2021 | Kadugodi, Karnataka, India | ActiveUsk Therapeutics Private Limited, a active private limited company, was established on 27 September 2021 in Kadugodi, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290KA2021PTC152293. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Employing 25 professional, Its leadership includes Sadu Kameswari (Managing Director), Sobha Velamuru (Director), Katakam Ushasree (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No 102, 1St Floor, Sv Elegant Syno.2/1 & 2/7,Kumbena Agrahara,Belathur, Kadugodi, Karnataka, 560067.
U24290KA2021PTC152293
152293
27 September 2021
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Usk Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sadu Kameswari | Managing Director | 27 Sep 2021 | Current |
| Sobha Velamuru | Director | 27 Sep 2021 | Current |
| Katakam Ushasree | Director | 27 Sep 2021 | Current |
| Puchalapalli Sankeerthi | Director | 27 Sep 2021 | Current |
| Ramakrishna Reddy Madakala | Director | 27 Sep 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Usk Therapeutics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 211.69% increase in profit. The company's net worth Soared by an impressive increase of 274.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Usk Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Usk Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Usk Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usk Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Usk Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Usk Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
The activity Sadu Kameswari was appointed as a Managing Director was appointed as a Managing Director on 27 Sep 2021 & has been associated with this company since 4 years 2 months . was completed.
The activity Sobha Velamuru was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 4 years 2 months . was completed.
Progress on Katakam Ushasree was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 4 years 2 months . was documented.
Progress on Puchalapalli Sankeerthi was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 4 years 2 months . was documented.
The CIN of Usk Therapeutics Private Limited is U24290KA2021PTC152293.
Usk Therapeutics Private Limited is headquartered at Flat No 102, 1St Floor, Sv Elegant Syno.2/1 & 2/7,Kumbena Agrahara,Belathur, Kadugodi, Karnataka, 560067.
Usk Therapeutics Private Limited was incorporated on 27 September 2021.
The current directors of Usk Therapeutics Private Limited are
The primary industry of Usk Therapeutics Private Limited is Manufacturing.
Usk Therapeutics Private Limited is unlisted.
The authorized capital of Usk Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX